Global Neuroprotection Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Neuroprotection Revenue
• 1.4 Market by Type
  • 1.4.1 Global Neuroprotection Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Free Anti-Inflammatory Agents
  • 1.4.3 Radical Trapping Agents (Antioxidants)
  • 1.4.4 Apoptosis Inhibitors
  • 1.4.5 Glutamate Antagonists (Anti-Excitotoxic Agents)
  • 1.4.6 Neurotrophic Factors (NTFs)
  • 1.4.7 Stimulants
  • 1.4.8 Metal Ion Chelators
  • 1.4.9 Other Products
• 1.5 Market by Application
  • 1.5.1 Global Neuroprotection Market Share by Application: 2020 VS 2026
  • 1.5.2 Prevention
  • 1.5.3 Treatment
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Neuroprotection Market Perspective (2015-2026)
• 2.2 Global Neuroprotection Growth Trends by Regions
  • 2.2.1 Neuroprotection Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Neuroprotection Historic Market Share by Regions (2015-2020)
  • 2.2.3 Neuroprotection Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Neuroprotection Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Neuroprotection Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Neuroprotection Players by Market Size
  • 3.1.1 Global Top Neuroprotection Players by Revenue (2015-2020)
  • 3.1.2 Global Neuroprotection Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Neuroprotection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Neuroprotection Market Concentration Ratio
  • 3.2.1 Global Neuroprotection Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Neuroprotection Revenue in 2019
• 3.3 Neuroprotection Key Players Head office and Area Served
• 3.4 Key Players Neuroprotection Product Solution and Service
• 3.5 Date of Enter into Neuroprotection Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Neuroprotection Historic Market Size by Type (2015-2020)
• 4.2 Global Neuroprotection Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Neuroprotection Market Size by Application (2015-2020)
• 5.2 Global Neuroprotection Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Neuroprotection Market Size (2015-2020)
• 6.2 Neuroprotection Key Players in North America (2019-2020)
• 6.3 North America Neuroprotection Market Size by Type (2015-2020)
• 6.4 North America Neuroprotection Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Neuroprotection Market Size (2015-2020)
• 7.2 Neuroprotection Key Players in Europe (2019-2020)
• 7.3 Europe Neuroprotection Market Size by Type (2015-2020)
• 7.4 Europe Neuroprotection Market Size by Application (2015-2020)

8 China

• 8.1 China Neuroprotection Market Size (2015-2020)
• 8.2 Neuroprotection Key Players in China (2019-2020)
• 8.3 China Neuroprotection Market Size by Type (2015-2020)
• 8.4 China Neuroprotection Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Neuroprotection Market Size (2015-2020)
• 9.2 Neuroprotection Key Players in Japan (2019-2020)
• 9.3 Japan Neuroprotection Market Size by Type (2015-2020)
• 9.4 Japan Neuroprotection Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Neuroprotection Market Size (2015-2020)
• 10.2 Neuroprotection Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Neuroprotection Market Size by Type (2015-2020)
• 10.4 Southeast Asia Neuroprotection Market Size by Application (2015-2020)

11 India

• 11.1 India Neuroprotection Market Size (2015-2020)
• 11.2 Neuroprotection Key Players in India (2019-2020)
• 11.3 India Neuroprotection Market Size by Type (2015-2020)
• 11.4 India Neuroprotection Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Neuroprotection Market Size (2015-2020)
• 12.2 Neuroprotection Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Neuroprotection Market Size by Type (2015-2020)
• 12.4 Central & South America Neuroprotection Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 F. Hoffmann-La Roche
  • 13.1.1 F. Hoffmann-La Roche Company Details
  • 13.1.2 F. Hoffmann-La Roche Business Overview
  • 13.1.3 F. Hoffmann-La Roche Neuroprotection Introduction
  • 13.1.4 F. Hoffmann-La Roche Revenue in Neuroprotection Business (2015-2020))
  • 13.1.5 F. Hoffmann-La Roche Recent Development
• 13.2 Eli Lilly and Company
  • 13.2.1 Eli Lilly and Company Company Details
  • 13.2.2 Eli Lilly and Company Business Overview
  • 13.2.3 Eli Lilly and Company Neuroprotection Introduction
  • 13.2.4 Eli Lilly and Company Revenue in Neuroprotection Business (2015-2020)
  • 13.2.5 Eli Lilly and Company Recent Development
• 13.3 Daiichi Sankyo Company
  • 13.3.1 Daiichi Sankyo Company Company Details
  • 13.3.2 Daiichi Sankyo Company Business Overview
  • 13.3.3 Daiichi Sankyo Company Neuroprotection Introduction
  • 13.3.4 Daiichi Sankyo Company Revenue in Neuroprotection Business (2015-2020)
  • 13.3.5 Daiichi Sankyo Company Recent Development
• 13.4 Allergan
  • 13.4.1 Allergan Company Details
  • 13.4.2 Allergan Business Overview
  • 13.4.3 Allergan Neuroprotection Introduction
  • 13.4.4 Allergan Revenue in Neuroprotection Business (2015-2020)
  • 13.4.5 Allergan Recent Development
• 13.5 Novartis
  • 13.5.1 Novartis Company Details
  • 13.5.2 Novartis Business Overview
  • 13.5.3 Novartis Neuroprotection Introduction
  • 13.5.4 Novartis Revenue in Neuroprotection Business (2015-2020)
  • 13.5.5 Novartis Recent Development
• 13.6 AstraZeneca
  • 13.6.1 AstraZeneca Company Details
  • 13.6.2 AstraZeneca Business Overview
  • 13.6.3 AstraZeneca Neuroprotection Introduction
  • 13.6.4 AstraZeneca Revenue in Neuroprotection Business (2015-2020)
  • 13.6.5 AstraZeneca Recent Development
• 13.7 Dr. Reddy's Laboratories
  • 13.7.1 Dr. Reddy's Laboratories Company Details
  • 13.7.2 Dr. Reddy's Laboratories Business Overview
  • 13.7.3 Dr. Reddy's Laboratories Neuroprotection Introduction
  • 13.7.4 Dr. Reddy's Laboratories Revenue in Neuroprotection Business (2015-2020)
  • 13.7.5 Dr. Reddy's Laboratories Recent Development
• 13.8 Astrocyte Pharmaceuticals
  • 13.8.1 Astrocyte Pharmaceuticals Company Details
  • 13.8.2 Astrocyte Pharmaceuticals Business Overview
  • 13.8.3 Astrocyte Pharmaceuticals Neuroprotection Introduction
  • 13.8.4 Astrocyte Pharmaceuticals Revenue in Neuroprotection Business (2015-2020)
  • 13.8.5 Astrocyte Pharmaceuticals Recent Development
• 13.9 Teva Pharmaceutical Industries
  • 13.9.1 Teva Pharmaceutical Industries Company Details
  • 13.9.2 Teva Pharmaceutical Industries Business Overview
  • 13.9.3 Teva Pharmaceutical Industries Neuroprotection Introduction
  • 13.9.4 Teva Pharmaceutical Industries Revenue in Neuroprotection Business (2015-2020)
  • 13.9.5 Teva Pharmaceutical Industries Recent Development
• 13.10 Biogen
  • 13.10.1 Biogen Company Details
  • 13.10.2 Biogen Business Overview
  • 13.10.3 Biogen Neuroprotection Introduction
  • 13.10.4 Biogen Revenue in Neuroprotection Business (2015-2020)
  • 13.10.5 Biogen Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer